Chamber and committees

There are additional treatment options for selected groups of people with COVID-19 who are thought to be at high risk with a prioritised clinical condition, as well as those taking part in registered clinical trials related to COVID-19. The high risk group does include those with rare neurological conditions such as:

• multiple sclerosis
• motor neurone disease
• myasthenia gravis
• Huntington’s disease

The decision on whether to prescribe a medicine for a patient is entirely for their clinician. Information on the arrangements for direct access to COVID-19 treatments in Scotland can be found at: Coronavirus (COVID-19): Treatments | NHS inform .

High risk individuals who have been diagnosed with chronic neurological disease are now included in the clinical risk group of the autumn/winter booster programme as advised by the Joint Committee on Vaccination and Immunisation (JCVI).

The following groups will be offered an additional booster dose from Sept 2022:

• residents in a care home for older adults and staff working in care homes for older adults
• frontline health and social care workers
• all adults aged 50 years and over
• those aged 5 to 49 years in a clinical risk group, including pregnant women
• those aged 5 to 49 years who are household contacts of people with immunosuppression
• carers aged 16-49 years

Letters will be sent out to the first eligible groups next month with appointments beginning in Sept. Discussions on the details of the delivery timetable are underway with health board partners. More information will be made available in due course.

Potential extension of the Waverley line, to Carlisle via Langholm, and other route variations, was appraised as part of the second Strategic Transport Projects Review (STPR2). Whilst the outcome was that the extension of the line was not included within the 45 draft recommendations, there does remain a path for regional or local rail projects to come forward, and Transport Scotland will consider these subject to a strong business case being developed in accordance with Scottish Transport Appraisal Guidance (STAG) and suitable funding being available. The Scottish Government have committed up to £5 million through the Borderlands Inclusive Growth Deal to enable regional partners to assess the benefits and challenges of extending the Borders Railway, and continue to work with partners to implement that commitment.

Through the Borderlands Inclusive Deal the Scottish Government have allocated up to £5 million to assess the benefits and challenges of extending the Borders Railway. That funding will be released on the achievement of agreed milestones, in line with the usual business case and governance processes that apply to all growth deal projects. As this is a joint funding commitment, the Scottish Government are currently awaiting the outcome of internal UK Government discussions on governance procedures to be able to align advice to partners and move things forward.

There are 15 prisons located throughout Scotland, 2 of which are managed privately.

Responsibility for providing prison healthcare was transferred from Scottish Prison Service (SPS) to NHS in 2011, and as such the Scottish Government does not hold data on the mental health workforce.

Data such as the number of staff in post or vacancies is collected on specific job roles but not within specific settings such as prisons.

While the Scottish Government provides funding for recruitment under Action 15, workforce and service planning is conducted by Integration Authorities according to the needs of their populations.

Under Action 15 of the Mental Health Strategy 2017-27, 54.4 whole time equivalent (WTE) mental health posts have been recruited to in our prisons.

As of 19 July 2022 we had issued 79 letters to people receiving Personal Independence Payment to let them know the transfer of their award to Adult Disability Payment has begun. These cases were selected as part of our small Personal Independence Payment to Adult Disability Payment pilot. Once Adult Disability Payment launches nationally on 29 August, we will begin selecting large numbers of Disability Living Allowance and Personal Independence Payment awards for transfer.

We have also developed and are delivering a strategic communication and engagement plan for case transfer. This includes a series of stakeholder roadshows to key stakeholders as well as stakeholder newsletters. We have also included case transfer messaging in our Adult Disability Payment communications such as media releases, opinion pieces, social media posts on Scottish Government and Social Security Scotland channels and paid for marketing campaigns that have run in the pilot areas. Paid for activity has covered radio, social media, digital and print. We will continue implementing this communication and engagement plan as the case transfer process continues.

The guidelines for the diagnosis of thrombosis and similar artery and vein clot conditions are provided by the Scottish Intercollegiate Guidelines Network (SIGN), specifically SIGN 122 for the prevention and management of venous thromboembolism.

The Diagnostics in Scotland Strategic Group (DiSSG) is the national group that holds responsibility for ensuring the continued coherent development and delivery of high quality diagnostic services in Scotland. The DiSSG acts as an advisory board including providing strategic direction and advice on new diagnostic tests.

The NHS Recovery Plan commits to innovation in diagnostic procedures and an increase in capacity over the next 5 years of 90,000 procedures by 2025-26, including diagnostics of thrombosis and similar artery and vein clot conditions.

Case transfer is a joint programme between the Scottish Government and the Department for Work and Pensions. We aim to have safely and securely transferred the awards of everyone living in Scotland in receipt of devolved disability and carer benefits currently delivered by the Department of Work and Pensions to Social Security Scotland by the end of 2025.

From 29 August 2022, adults in Scotland in receipt of Disability Living Allowance will have their awards moved to Adult Disability Payment if they would otherwise have been asked by the Department for Work and Pensions to apply for Personal Independence Payment. Final policy is still being developed on moving the awards of all other adults currently in receipt of Disability Living Allowance.

It is not possible to provide the percentage of individuals admitted to NHS Scotland who are assessed for venous thromboembolism (VTE) as this data is not routinely recorded.

The General/Acute and Inpatient Day case Dataset (SMR01) contains records where pulmonary embolism and phlebitis and thrombophlebitis of the lower extremities are listed as the primary diagnosis.

These conditions are usually recorded in an inpatient setting, on the SMR01. The structure of the International Classification of Disease and Related Health Problems 10 revision (ICD10) does not allow for easy identification of Venous Thromboembolism.

I refer the member to the answer to question S6W-08833 on 14 June 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

The Scottish Government has recently announced a new set of ambitious targets to eliminate long waits, with an initial focus on long waits over two years for new outpatients by August 2022 and for inpatients and day case procedures by September 2022.

We have recently stepped down the Clinical Prioritisation Framework that was in place since November 2020 to help Boards prioritise waiting lists throughout the Covid-19 pandemic.

This move is a return to pre-pandemic approach of treating patients on an urgent and routine basis, giving Health Boards and clinicians full flexibility to manage waiting lists with a focus on eliminating long waits, as well as continuing to treat the most clinically urgent patients.